Special Issue "Smoking, Vaping and COVID-19"
A special issue of International Journal of Environmental Research and Public Health (ISSN 1660-4601). This special issue belongs to the section "Global Health".
Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 26446
Interests: addiction; nicotine; tobacco; vaping; cannabis; mental health; treatment
Interests: tobacco; cannabis; disparities; risk perceptions;
Interests: tobacco; cannabis; multiple health risk behaviors; digital health; social media;
The COVID-19 pandemic has had widespread effects. Restrictions on social and occupational activities have dramatically altered daily routines; retailers have been restricted; and personal experiences with isolation, illness, and economic effects have led to uncertainty, immense stress, and grief. While prior evidence indicates smoking is associated with a greater risk of developing respiratory illness and a more difficult time recovering from respiratory illness effects, initial reports (non-peer-reviewed) analyzing data from China indicate tobacco smoking may be associated with decreased risk of COVID-19 severity. Other studies, peer-reviewed, indicate worse outcomes among individuals with co-occurring disorders such as chronic obstructive pulmonary disease (COPD), for which the prevailing risk factor is chronic tobacco smoking. In the months just prior to COVID-19, EVALI (e-cigarette or vaping product use associated lung injury) raised national attention and concern about nicotine and cannabis vaping effects on respiratory function, morbidity, and mortality. To inform health policy, public health guidance, and treatment interventions, peer-reviewed research is needed on the effects of smoking and vaping in relation to lung health and COVID-19. Specifically, research is needed to identify smoking- and vaping-related risk factors for COVID-19 development, severity, and progression. This Special Issue in IJERPH has a focus on smoking and vaping of tobacco/nicotine and cannabis products and spans epidemiology to treatment, policy, and the retail environment. Areas of interest include:
- Prevalence of COVID-19 among those who smoke or vape;
- COVID-19 related risk perceptions among those who smoke or vape;
- COVID-19 related changes in access to smoking or vaping products and shifts in the retailer environment (e.g., essential business designation, home delivery, vaping/flavor bans);
- COVID-19 disease progression and severity in the presence of smoking or vaping;
- Secondhand smoke exposure in relation to COVID-19 shelter-in-place restrictions;
- Treatment seeking, quit attempts, and sustained cessation of smoking and vaping associated with COVID-19 risk perceptions and restrictions.
Dr. Judith J. Prochaska
Dr. Kathleen Gali
Dr. Erin A. Vogel
Dr. Kelly C. Young-Wolff
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Environmental Research and Public Health is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- novel coronavirus
- risk perceptions